NCT06848530View on ClinicalTrials.gov

Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Movement Disorders
Interventions
OTHER

Prescribed Medications

participant's movement disorders medications, prescribed by their treating physician

OTHER

Deep brain stimulation adjustment

Deep brain stimulator parameters may be adjusted within normal clinical limits

Trial Locations (1)

19107

Pennsylvania Hospital, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT06848530 - Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders | Biotech Hunter | Biotech Hunter